Research on gut microbiome effects on pediatric diseases
Prediction and Treatment of Pediatric Diseases and Long-term Outcomes Through Microbiome and Multi-Omics Study by Life Cycle
This study is testing how changes in the gut bacteria of children, including newborns, might be linked to different health issues to better understand their impact on long-term health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | All |
| Sponsor | Hanyang University Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06812091 on ClinicalTrials.gov |
What this trial studies
This study investigates the relationship between gut microbiome dysbiosis and various pediatric diseases by analyzing fecal samples from children, including newborns. It employs high-throughput sequencing and multi-omics analyses to categorize children into disease groups and assess changes in their microbiome over time. The research aims to provide insights into the gut-lung and gut-brain axes and how these interactions affect long-term health outcomes in children.
Who should consider this trial
Good fit: Ideal candidates for this study are children, including newborns, whose guardians have provided consent.
Not a fit: Patients who do not have consent from their guardians will not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of pediatric diseases linked to gut microbiome imbalances.
How similar studies have performed: Other studies have shown promising results in understanding the microbiome's role in health, suggesting potential for success in this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * children (including newborns) who have obtained their consent from their guardians Exclusion Criteria: * subjects who did not obtain consent
Where this trial is running
Seoul
- Hanyang University Medical Center — Seoul, South Korea (Recruiting)
Study contacts
- Principal investigator: Hyun-Kyung Park, MD — Hanyang University
- Study coordinator: Hyun-Kyung Park, MD
- Email: neopark@hanyang.ac.kr
- Phone: 82-10-4749-1454
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.